Related Experiment Videos
Polymorphism of human cytochrome P-450.
Summary
Researchers purified human liver cytochrome P-450 enzymes responsible for drug metabolism, including those for debrisoquine (P-450DB) and phenacetin (P-450PA). Studies confirmed their roles in polymorphic drug oxidation and identified rat orthologs.
Area of Science:
- Biochemistry
- Pharmacology
- Genetics
Background:
- Cytochrome P-450 enzymes are crucial for drug metabolism in humans.
- Polymorphisms in these enzymes lead to variations in drug response.
- Specific P-450 forms (P-450DB, P-450PA, P-450MP, P-450NF) are known to exhibit in vivo polymorphism.
Purpose of the Study:
- To purify and characterize human liver cytochrome P-450 enzymes involved in key drug metabolism reactions.
- To identify and compare the rat orthologs of these human enzymes.
- To elucidate the specific catalytic activities of the purified P-450 forms.
Main Methods:
- Purification of human liver microsomes to isolate specific cytochrome P-450 forms.
- In vitro reconstitution assays to confirm enzyme activity.
- Immunoinhibition studies to verify enzyme function.
- Isolation of a cDNA clone for rat P-450UT-H.
- mRNA analysis to investigate gene expression variations.
Main Results:
- Four human cytochrome P-450 enzymes (P-450DB, P-450PA, P-450MP, P-450NF) were purified.
- Specific substrates were identified for each purified enzyme, including debrisoquine, phenacetin, S-mephenytoin, and nifedipine.
- Rat orthologs were identified, with P-450UT-H being the primary ortholog for P-450DB.
- A cDNA clone for rat P-450UT-H was isolated, and its mRNA levels correlated with variations in debrisoquine 4-hydroxylase activity.
Conclusions:
- The purified human P-450 enzymes are responsible for specific drug metabolism pathways.
- Understanding these enzymes and their genetic variations is key to personalized medicine.
- Differences in mRNA levels of rat P-450UT-H contribute to metabolic variations.